Iovance Biotherapeutics (IOVA) Receivables - Other (2011)

Iovance Biotherapeutics (IOVA) posted quarterly Receivables - Other of $50000.0 for Q3 2011, little changed quarter-over-quarter from $50000.0 in Q2 2011.

Iovance Biotherapeutics (IOVA) Receivables - Other (2011) Analysis & Trends

Iovance Biotherapeutics (IOVA) has reported Receivables - Other for 1 consecutive years, with $50000.0 the latest figure, recorded in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Iovance Biotherapeutics 3.16 Bn 2.86 Bn 55.72 Mn

Historic Data

Download Data
DateValue
Sep 30, 2011 50,000.00
Sep 30, 2011 50,000.00
Jun 30, 2011 50,000.00
Jun 30, 2011 50,000.00